Investing
Schott Pharma sets IPO price at €27, targets €4.1B market cap
© Reuters.
German pharmaceutical company Schott Pharma is set to make its debut on the Frankfurt Stock Exchange, having set its initial public offering (IPO) price at €27 ($28.36). The pricing, announced on Thursday, falls within the projected range of €24.50 and €28.50.
The valuation puts Schott Pharma’s market capitalization at around €4.1 billion. The firm anticipates gross proceeds of €935 million from the sale of 34.6 million shares. The parent company, Schott, plans to retain a significant majority stake of at least 77% following the IPO.
In a noteworthy development, Qatar Holding has secured a 4.9% stake in Schott Pharma through an investment of €200 million. The IPO and subsequent listing on the Frankfurt Stock Exchange represent a significant milestone for Schott Pharma in its growth trajectory. It will be closely watched by investors and industry stakeholders alike as it unfolds.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
-
Investing7 days ago
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
-
Side Hustles7 days ago
VP Exec’s Top Tips for Negotiating and Relationship-Building
-
Personal Finance4 days ago
Social Security cost-of-living adjustment will be 2.5% in 2025, less than prior year
-
Side Hustles7 days ago
Why the Smallest Details Mean the Most in Marketing
-
Investing6 days ago
U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 1.37% By Investing.com
-
Investing7 days ago
Britain’s FTSE 100 rises as oil price jump boosts energy shares By Reuters
-
Make Money6 days ago
The Top Employers and Opportunities for Part-Time Remote Jobs
-
Passive Income6 days ago
How to Build a Workplace Culture Centered on Love, Abundance and Purpose